We are live on ! Find out more
Bank Julius Baer & Co

Bank Julius Baer & Co Portfolio holdings

AUM $33.2B
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+25.01%
3 Year Est. Return
+91.4%
5 Year Est. Return
+116.23%
10 Year Est. Return
AUM
$13.4B
AUM Growth
+$1.17B
Cap. Flow
+$978M
Cap. Flow %
7.33%
Top 10 Hldgs %
32.99%
Holding
925
New
124
Increased
306
Reduced
365
Closed
113

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$94.1M
2
MA icon
Mastercard
MA
+$93.1M
3
V icon
Visa
V
+$75.8M
4
CDNS icon
Cadence Design Systems
CDNS
+$70.9M
5
MMM icon
3M
MMM
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 23.73%
2 Healthcare 16.05%
3 Financials 12.84%
4 Communication Services 8.96%
5 Consumer Discretionary 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
751
Repligen
RGEN
$9.25B
$19K ﹤0.01%
100
-150
-60% -$30.8K
ICPT
752
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$19K ﹤0.01%
815
+5
+0.6% +$139
STL
753
DELISTED
Sterling Bancorp
STL
$19K ﹤0.01%
+814
New +$17.5K
LTRN icon
754
Lantern Pharma
LTRN
$36.5M
$18K ﹤0.01%
+1,000
New +$17.5K
VIPS icon
755
Vipshop
VIPS
$7.53B
$18K ﹤0.01%
+607
New +$20.9K
IEFA icon
756
iShares Core MSCI EAFE ETF
IEFA
$196B
$17K ﹤0.01%
235
+3
+1% +$214
PAAS icon
757
Pan American Silver
PAAS
$21.6B
$17K ﹤0.01%
580
PBR icon
758
Petrobras
PBR
$116B
$17K ﹤0.01%
+1,960
New +$18.7K
ACB
759
Aurora Cannabis
ACB
$185M
$16K ﹤0.01%
+175
New +$19.6K
BCLI
760
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$16K ﹤0.01%
278
-2
-0.7% -$151
PKG icon
761
Packaging Corp of America
PKG
$22.8B
$16K ﹤0.01%
120
+4
+3% +$545
RPRX icon
762
Royalty Pharma
RPRX
$25.3B
$16K ﹤0.01%
375
-25
-6% -$1.19K
CHKP icon
763
Check Point Software Technologies
CHKP
$13.1B
$15K ﹤0.01%
135
-113
-46% -$13.6K
KSS icon
764
Kohl's
KSS
$2.19B
$15K ﹤0.01%
251
+5
+2% +$257
DYAI icon
765
Dyadic International
DYAI
$36.4M
$14K ﹤0.01%
2,500
+455
+22% +$2.52K
NOK icon
766
Nokia
NOK
$52.3B
$14K ﹤0.01%
+3,632
New +$15.2K
WKHS icon
767
Workhorse Group
WKHS
$36.3M
-5
Closed -$359K
CHIH
768
DELISTED
Global X MSCI China Health Care ETF
CHIH
$14K ﹤0.01%
501
-999
-67% -$28.9K
LUMN icon
769
Lumen
LUMN
$6.44B
$13K ﹤0.01%
1,002
-24
-2% -$298
PRVB
770
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$13K ﹤0.01%
+1,250
New +$17.6K
CLRB icon
771
Cellectar Biosciences
CLRB
$20.5M
$12K ﹤0.01%
+25
New +$14.9K
GLW icon
772
Corning
GLW
$143B
$12K ﹤0.01%
+273
New +$10.5K
DXJ icon
773
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
$11K ﹤0.01%
173
-1,481
-90% -$86.4K
KRBN icon
774
KraneShares Global Carbon Strategy ETF
KRBN
$133M
$11K ﹤0.01%
+400
New +$10.9K
NOC icon
775
Northrop Grumman
NOC
$81.2B
$11K ﹤0.01%
35
-168
-83% -$50.7K

Similar funds

Bank Julius Baer & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Bank Julius Baer & Co held 925 positions worth $13.4B, up 9.6% from $12.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bank Julius Baer & Co deployed $978M of net new capital in Q1 2021, opening 124 new positions and adding to 306 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 1,254,550 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $94.1M trimmed.

  • Bank Julius Baer & Co's largest Q1 2021 buy was Vanguard Short-Term Corporate Bond ETF: 1,254,550 shares worth $104M.
  • Bank Julius Baer & Co added most to JPMorgan Chase in Q1 2021, an estimated $137M increase.
  • Bank Julius Baer & Co's biggest Q1 2021 reduction was Salesforce, cutting an estimated $94.1M.
  • Bank Julius Baer & Co fully exited Invesco Equal Weight 0-30 Year Treasury ETF in Q1 2021, selling an estimated $12.1M.
  • Bank Julius Baer & Co's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Bank Julius Baer & Co opened 124 new positions and closed 113 in Q1 2021.
  • Bank Julius Baer & Co's portfolio value rose 9.6% quarter-over-quarter to $13.4B.

Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.